CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

AbbVie-allied ADARx aims for IPO with 3 drugs in the clinic

IPO/OfferingPositive
AI Analysis

Summary

ADARx Pharmaceuticals, an AbbVie-allied RNA interference company with three drugs in clinical development, filed for IPO, aiming to capitalize on biotech sector momentum.

Importance:6/10
Sentiment:
0.60
IPORNA interferenceclinical stageAbbVie-backed
Related Companies

Read the original article

Published by Endpoints News on September 5, 2026 7:42 AM

Read Original